This inventor holds 1 USPTO granted patent. Top assignee: Korea Research Institute of Bioscience. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Sol Ji Jung: Innovator in Natural Killer Cell Research
Introduction
Sol Ji Jung is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of bioscience, particularly in the development of innovative methods for producing memory-like natural killer (NK) cells. His work has the potential to advance cancer treatment methodologies.
Latest Patents
Sol Ji Jung holds a patent titled "Method for producing memory-like NK cells with ability to express higher levels of NCRs, cytotoxicity, and IFN-γ than NK cells in human peripheral blood." This patent describes a method for producing memory-like NK cells that exhibit enhanced capabilities, including a higher level of natural killer cell receptors, improved cytotoxicity, and increased production of IFN-γ compared to standard NK cells found in human peripheral blood. The implications of this research are significant for cancer treatment, as it offers a novel approach to harnessing the immune system's potential.
Career Highlights
Sol Ji Jung is affiliated with the Korea Research Institute of Bioscience, where he conducts his research. His work is characterized by a commitment to advancing scientific knowledge and improving therapeutic options for patients suffering from cancer. His innovative approach to cell production has garnered attention in the scientific community.
Collaborations
Some of his notable coworkers include Soo Yeon Park and Han Na Kim. Their collaborative efforts contribute to the ongoing research and development in the field of natural killer cell therapies.
Conclusion
In summary, Sol Ji Jung is a key figure in the advancement of natural killer cell research, with a focus on innovative methods that enhance cancer treatment. His contributions are paving the way for new therapeutic strategies that could significantly impact patient care.